Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
-
Comparative Study
Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
To assess the cost-effectiveness of oral capecitabine compared with intravenous bolus 5-fluorouracil/leucovorin (5-FU/LV) in the adjuvant treatment of stage III colon cancer in Taiwan from payer (Bureau of National Health Insurance [BNHI]) perspectives. ⋯ From the perspectives of the BNHI and society in Taiwan, capecitabine not only saves costs but also improves health outcomes compared with 5-FU/LV in the adjuvant treatment of stage III colon cancer.
-
Meta Analysis Comparative Study
Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis.
Methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and skin structure infection (cSSSI) is a prominent infection encountered in hospital and outpatient settings that is associated with high resource use for the health-care system. ⋯ Linezolid and daptomycin are potentially cost-effective based on the assumptions of the DA model; however, linezolid appears to be more cost-effective compared to daptomycin and vancomycin for MRSA cSSSIs.
-
Japan has the highest smoking prevalence among the G7 countries, and the Japanese government is expanding tobacco control measures, such as financial support for nicotine replacement therapy and cigarette price increases, to reduce smoking. In 2006, we examined intended quit attempts using hypothetical questions. Since then, a price increase for cigarettes has been proposed and has come closer to being realized. ⋯ The shift of preference for intended attempts to quit is diverse according to nicotine dependence. These differences may be derived from the variations of their time and risk preference and their trust in the tobacco price policies.
-
Multicenter Study
The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
The prevalence of type 2 diabetes has shown a significant increase in parallel with health care costs. The objective of the Brazilian Study on Diabetes Costs (ESCUDI study) was to estimate direct and indirect costs of type 2 diabetes outpatient care in the Brazilian Public Health Care System. ⋯ Diabetes treatment leads to elevated costs both to Brazilian Public Health Care System and society. Costs increased along with duration of disease, level of care and presence of chronic complications, which suggested a need to reallocate health resources focusing on primary prevention of diabetes and its complications.